Testing gut microbes and metabolites to predict rectal cancer outcomes
Part of Cancer, Digestive system clinical trials.
This study looks at patterns in the gut microbiome (gut bacteria) and gut chemicals (metabolites) to predict how rectal cancer may do after planned surgery. By understanding these markers, researchers hope to better forecast prognosis and tailor follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having planned (elective) surgery for rectal or colorectal disease
- You are age 18 or older
- Your diagnosis is adenocarcinoma or adenoma (with or without chemo or pre-surgery chemo-radiation)
- Your cancer is at least T1 stage, and your care team plans to remove it completely (R0 resection)
- You can sign consent and complete study questionnaires, including a diet questionnaire
- You can have this study if you do not have major exclusions like certain other cancers, major infections, or severe organ disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at stool samples to see whether gut bacteria or other microbes help explain why some rectal cancers respond less well to treatment given before surgery. If you have mid or lower rectal cancer and are planning pre-surgery treatment, your information and stool sample may help researchers improve how treatment is chosen.
This study uses MRI scans to try to predict whether your rectal cancer completely disappears after pre-surgery chemoradiotherapy. The goal is to better personalize treatment decisions, possibly helping some patients avoid surgery.
This study looks at how rectal cancer responds to the usual chemotherapy and radiation given before surgery. It aims to learn if certain molecular features of your tumor can predict how well it responds to treatment.
This trial studies lab “biomarkers” (measurable cancer features) to predict whether rectal cancer will resist chemo-radiation before surgery. The goal is to help doctors better choose treatments and avoid ineffective therapy.
This study looks at whether a genetic test on a small sample of your tumor can predict how well you will respond to chemotherapy and radiation before surgery. This might help doctors choose the best treatment for you.
This trial tests a program that helps you and your doctor decide together whether to avoid surgery and keep your rectum after chemo and radiation. It's for people with early-stage rectal cancer who have not had prior treatment for this cancer.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.